FULCFulcrum Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $8.04 (-0.50% today)

Market Cap: $435.06M

P/E (TTM): -6.80

Analyst Upside: 111.4%

Relative Strength (RS%): 14

-48.9% from 52-week high

Back to Scanner

FULC

NASDAQRS 14Score 17

Fulcrum Therapeutics, Inc.

HealthcareBiotechnology$435.06M1 setup passing
$8.04
-0.5% ($0.04)
-48.9% from 52W High
P/E (TTM)
-6.80
Fwd P/E
PEG
Analyst Upside
+111.4%
EPS Growth
Gross Margin
0.0%
ROE
-30.2%
D/E
0.02
Div Yield
0.0%
Avg Volume
1.0M

Price Chart

Key Levels

SMA 200
$8.79
SMA 50
$8.96
Price
$8.04
52W High
$15.73
Target
$17.00

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst